These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 28033507)

  • 1. Regulatory region genetic variation is associated with FYN expression in Alzheimer's disease.
    Zahratka JA; Shao Y; Shaw M; Todd K; Formica SV; Khrestian M; Montine T; Leverenz JB; Bekris LM
    Neurobiol Aging; 2017 Mar; 51():43-53. PubMed ID: 28033507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-106b inhibits tau phosphorylation at Tyr18 by targeting Fyn in a model of Alzheimer's disease.
    Liu W; Zhao J; Lu G
    Biochem Biophys Res Commun; 2016 Sep; 478(2):852-7. PubMed ID: 27520374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical residues involved in tau binding to fyn: implications for tau phosphorylation in Alzheimer's disease.
    Lau DH; Hogseth M; Phillips EC; O'Neill MJ; Pooler AM; Noble W; Hanger DP
    Acta Neuropathol Commun; 2016 May; 4(1):49. PubMed ID: 27193083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association of single nucleotide polymorphism of the Fyn gene with sporadic Alzheimer's disease in the Chinese Han population.
    Li J; Zhou HD; Deng J; Zhu J; Li L; Zhang M; Zeng F; Wang YJ;
    Neurosci Lett; 2014 Jul; 575():80-4. PubMed ID: 24852829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyk2 is a Novel Tau Tyrosine Kinase that is Regulated by the Tyrosine Kinase Fyn.
    Li C; Götz J
    J Alzheimers Dis; 2018; 64(1):205-221. PubMed ID: 29782321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered p59Fyn kinase expression accompanies disease progression in Alzheimer's disease: implications for its functional role.
    Ho GJ; Hashimoto M; Adame A; Izu M; Alford MF; Thal LJ; Hansen LA; Masliah E
    Neurobiol Aging; 2005 May; 26(5):625-35. PubMed ID: 15708437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tau phosphorylation pathway genes and cerebrospinal fluid tau levels in Alzheimer's disease.
    Bekris LM; Millard S; Lutz F; Li G; Galasko DR; Farlow MR; Quinn JF; Kaye JA; Leverenz JB; Tsuang DW; Yu CE; Peskind ER
    Am J Med Genet B Neuropsychiatr Genet; 2012 Oct; 159B(7):874-83. PubMed ID: 22927204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fyn Kinase Controls Tau Aggregation In Vivo.
    Briner A; Götz J; Polanco JC
    Cell Rep; 2020 Aug; 32(7):108045. PubMed ID: 32814048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The microtubule-associated protein tau is also phosphorylated on tyrosine.
    Lebouvier T; Scales TM; Williamson R; Noble W; Duyckaerts C; Hanger DP; Reynolds CH; Anderton BH; Derkinderen P
    J Alzheimers Dis; 2009; 18(1):1-9. PubMed ID: 19542604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fyn, a potential target for Alzheimer's disease.
    Yang K; Belrose J; Trepanier CH; Lei G; Jackson MF; MacDonald JF
    J Alzheimers Dis; 2011; 27(2):243-52. PubMed ID: 21799250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic variants of GSK3B are associated with biomarkers for Alzheimer's disease and cognitive function.
    Kettunen P; Larsson S; Holmgren S; Olsson S; Minthon L; Zetterberg H; Blennow K; Nilsson S; Sjölander A
    J Alzheimers Dis; 2015; 44(4):1313-22. PubMed ID: 25420549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No genetic association between Fyn kinase gene polymorphisms (-93A/G, IVS10+37T/C and Ex12+894T/G) and Japanese sporadic Alzheimer's disease.
    Watanabe T; Ohnuma T; Shibata N; Ohtsuka M; Ueki A; Nagao M; Arai H
    Neurosci Lett; 2004 Apr; 360(1-2):109-11. PubMed ID: 15082191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptomics and mechanistic elucidation of Alzheimer's disease risk genes in the brain and in vitro models.
    Martiskainen H; Viswanathan J; Nykänen NP; Kurki M; Helisalmi S; Natunen T; Sarajärvi T; Kurkinen KM; Pursiheimo JP; Rauramaa T; Alafuzoff I; Jääskeläinen JE; Leinonen V; Soininen H; Haapasalo A; Huttunen HJ; Hiltunen M
    Neurobiol Aging; 2015 Feb; 36(2):1221.e15-28. PubMed ID: 25281018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Up-regulation of phosphorylated/activated p70 S6 kinase and its relationship to neurofibrillary pathology in Alzheimer's disease.
    An WL; Cowburn RF; Li L; Braak H; Alafuzoff I; Iqbal K; Iqbal IG; Winblad B; Pei JJ
    Am J Pathol; 2003 Aug; 163(2):591-607. PubMed ID: 12875979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fine mapping of the MAPT locus using quantitative trait analysis identifies possible causal variants in Alzheimer's disease.
    Laws SM; Friedrich P; Diehl-Schmid J; Müller J; Eisele T; Bäuml J; Förstl H; Kurz A; Riemenschneider M
    Mol Psychiatry; 2007 May; 12(5):510-7. PubMed ID: 17179995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TAU haplotype and the Saitohin Q7R gene polymorphism do not influence CSF Tau in Alzheimer's disease and are not associated with frontotemporal dementia or Parkinson's disease.
    Johansson A; Zetterberg H; Håkansson A; Nissbrandt H; Blennow K
    Neurodegener Dis; 2005; 2(1):28-35. PubMed ID: 16909000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AlphaScreen HTS and live-cell bioluminescence resonance energy transfer (BRET) assays for identification of Tau-Fyn SH3 interaction inhibitors for Alzheimer disease.
    Cochran JN; Diggs PV; Nebane NM; Rasmussen L; White EL; Bostwick R; Maddry JA; Suto MJ; Roberson ED
    J Biomol Screen; 2014 Dec; 19(10):1338-49. PubMed ID: 25156556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinesin gene variability may affect tau phosphorylation in early Alzheimer's disease.
    Andersson ME; Sjölander A; Andreasen N; Minthon L; Hansson O; Bogdanovic N; Jern C; Jood K; Wallin A; Blennow K; Zetterberg H
    Int J Mol Med; 2007 Aug; 20(2):233-9. PubMed ID: 17611642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA sequence variations in the prolyl isomerase Pin1 gene and Alzheimer's disease.
    Poli M; Gatta LB; Dominici R; Lovati C; Mariani C; Albertini A; Finazzi D
    Neurosci Lett; 2005 Dec; 389(2):66-70. PubMed ID: 16095818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting Fyn Kinase in Alzheimer's Disease.
    Nygaard HB
    Biol Psychiatry; 2018 Feb; 83(4):369-376. PubMed ID: 28709498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.